Wednesday, August 9,
2023 at 8:30 am Eastern
Time
REDWOOD
CITY, Calif., July 12,
2023 /PRNewswire/ -- Nevro Corp. (NYSE:
NVRO), a global medical device company that is delivering
comprehensive, life-changing solutions for the treatment of chronic
pain, today announced that Kevin
Thornal, Nevro's CEO and President, and Rod MacLeod, Nevro's CFO, will present at the
Canaccord Genuity 43rd Annual Growth Conference on
Wednesday, August 9, 2023 at
8:30 am Eastern Time at the
InterContinental Boston Hotel in Boston,
MA.
A webcast of this event, as well as an archived recording, will
be available in the Investors section of Nevro's website at
www.nevro.com.
Internet Posting of Information
Nevro routinely posts information that may be important to
investors in the "Investor Relations" section of its website at
www.nevro.com. The company encourages investors and potential
investors to consult the Nevro website regularly for important
information about Nevro.
About Nevro
Headquartered in Redwood City,
California, Nevro is a global medical device company focused
on delivering comprehensive, life-changing solutions that continue
to set the standard for enduring patient outcomes in chronic pain
treatment. The company started with a simple mission to help more
patients suffering from debilitating pain and developed its
proprietary 10 kHz Therapy™, an evidence-based, non-pharmacologic
innovation that has impacted the lives of more than 100,000
patients globally. Nevro's comprehensive HFX™ spinal cord
stimulation (SCS) platform includes a Senza SCS system and support
services for the treatment of chronic pain of the trunk and limb
and painful diabetic neuropathy.
Senza®, Senza II®, Senza Omnia™, and HFX iQ™ are the only SCS
systems that deliver Nevro's proprietary 10 kHz Therapy™. Nevro's
unique support services provide every patient with an HFX Coach™
throughout their pain relief journey and every physician with HFX
Cloud™ insights for enhanced patient and practice management.
SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz
Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm,
HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo,
HFX COACH, the HFX Coach logo, HFX CLOUD, the HFX Cloud logo,
RELIEF MULTIPLIED, the X logo, NEVRO, and the NEVRO logo are
trademarks or registered trademarks of Nevro Corp. Patents covering
Senza HFX iQ and other Nevro products are listed at
Nevro.com/patents.
To learn more about Nevro, connect with us
on LinkedIn, Twitter, Facebook and Instagram.
Investors and Media:
Julie
Dewey, IRC
Nevro Corp.
Chief Corp Communications and Investor Relations Officer
650-433-3247 | julie.dewey@nevro.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nevro-to-present-at-the-canaccord-genuity-43rd-annual-growth-conference-301870949.html
SOURCE Nevro Corp.